Transition Between Treatments: What We Need to Know

被引：0

作者：

Minden, Kirsten ^{[1
,2
,3
,4
,5
]}

Klotsche, Jens ^{[1
]}

机构：

[1] German Rheumatism Res Ctr Berlin, Leibniz Inst, Epidemiol Unit, Berlin, Germany

[2] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany

[3] Free Univ Berlin, Berlin, Germany

[4] Humboldt Univ, Berlin, Germany

[5] Berlin Inst Hlth, Berlin, Germany

来源：

JOURNAL OF RHEUMATOLOGY | 2021年 / 48卷 / 08期

关键词：

JUVENILE IDIOPATHIC ARTHRITIS; CHILDREN; DISEASE; COHORT;

D O I：

10.3899/jrheum.201331

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1198 / 1200

页数：3

共 20 条

[1] Biological agents in polyarticular juvenile idiopathic arthritis: A meta-analysis of randomized withdrawal trials
Amarilyo, Gil
Tarp, Simon
Foeldvari, Ivan
Cohen, Neta
Pope, Tracy D.
Woo, Jennifer M. P.
Christensen, Robin
Furst, Daniel E.
[J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 46 (03) : 312 - 318
[2] A new Canadian inception cohort for juvenile idiopathic arthritis: The Canadian Alliance of Pediatric Rheumatology Investigators Registry
Batthish, Michelle
Berard, Roberta
Cabral, David
Bolaria, Roxana
Chedeville, Gaelle
Duffy, Ciaran
Gerhold, Kerstin
Gerschman, Tommy
Huber, Adam
Proulx-Gauthier, Jean-Philippe
Rosenberg, Alan
Rumsey, Dax
Schmeling, Heinrike
Shiff, Natalie
Soon, Gordon
Bruns, Alessandra
Tucker, Lori
Guzman, Jaime
[J]. RHEUMATOLOGY, 2020, 59 (10) : 2796 - 2805
[3] Bruni C., 2020, CLIN RHEUMATOL
[4] Real-World Effectiveness of Common Treatment Strategies for Juvenile Idiopathic Arthritis: Results From a Canadian Cohort
Chhabra, Amieleena
Oen, Kiem
Huber, Adam M.
Shiff, Natalie J.
Boire, Gilles
Benseler, Susanne M.
Berard, Roberta A.
Scuccimarri, Rosie
Feldman, Brian M.
Lim, Lily Siok Hoon
Barsalou, Julie
Bruns, Alessandra
Cabral, David A.
Chedeville, Gaelle
Ellsworth, Janet
Houghton, Kristin
Lang, Bianca
Morishita, Kimberly
Rumsey, Dax G.
Rosenberg, Alan M.
Tse, Shirley M.
Watanabe Duffy, Karen
Duffy, Ciaran M.
Guzman, Jaime
[J]. ARTHRITIS CARE & RESEARCH, 2020, 72 (07) : 897 - 906
[5] Disease modifying anti-rheumatic drugs in juvenile idiopathic arthritis: striving for individualized therapy
Funk, Ryan S.
Becker, Mara L.
[J]. EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2016, 1 (01): : 53 - 68
[6] Facing Real-World Challenges of Immunogenicity in Pediatric Inflammatory Bowel Disease
Gress, Kyle
Bass, Julie A.
Funk, Ryan S.
Morrow, Ryan P.
Hasenkamp, Rachel
Shakhnovich, Valentina
[J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
[7] Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab
Horneff, Gerd
Klein, Ariane
Klotsche, Jens
Minden, Kirsten
Huppertz, Hans-Iko
Weller-Heinemann, Frank
Kuemmerle-Deschner, Jasmin
Haas, Johannes-Peter
Hospach, Anton
[J]. ARTHRITIS RESEARCH & THERAPY, 2016, 18
[8] Timing matters: real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis
Huang, Bin
Qiu, Tingting
Chen, Chen
Zhang, Yin
Seid, Michael
Lovell, Dan
Brunner, Hermine I.
Morgan, Esi M.
[J]. RMD OPEN, 2020, 6 (01):
[9] Frequency of biologic switching and the outcomes of switching in children and young people with juvenile idiopathic arthritis: a national cohort study
Kearsley-Fleet, Lianne
Heaf, Eleanor
Davies, Rebecca
Baildam, Eileen
Beresford, Michael W.
Foster, Helen E.
Southwood, Taunton R.
Thomson, Wendy
Hyrich, Kimme L.
[J]. LANCET RHEUMATOLOGY, 2020, 2 (04) : E217 - E226
[10] Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)
Klotsche, Jens
Niewerth, Martina
Haas, Johannes-Peter
Huppertz, Hans-Iko
Zink, Angela
Horneff, Gerd
Minden, Kirsten
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (05) : 855 - 861

← 1 2 →